Genifloz Pharmacon Private Limited - Company Profile

It is a paper private limited company based in Beleghata, West Bengal, India, established in 2025.
2025 Beleghata, West Bengal, India Active
Last Updated:
About Genifloz Pharmacon Private Limited

Genifloz Pharmacon Private Limited, a active private limited company, was established on 14 February 2025 in Beleghata, West Bengal, India. Engaging in paper & paper products within the paper sector, it holds CIN: U21001WB2025PTC276443. Registered under ROC Roc Kolkata. it is unlisted. It has an authorized capital of ₹1.50 M and a paid-up capital of ₹0.20 M.

Its leadership includes Prasenjit Goswami (Director), Manjulika Sardar (Director), Siddhartha Sankar Roy (Additional Director). It is based at P-183, C.I.T. Road,, Phool Bagan, Beleghata, Beleghata, West Bengal, 700010.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U21001WB2025PTC276443

  • Registration Number

    276443

  • Incorporation Date

    14 February 2025

  • Authorized Capital

    ₹1.50 M

  • Paid-Up Capital

    ₹0.20 M

  • ROC Code

    Roc Kolkata

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.50 M
  • Paid Up Capital ₹ 0.20 M
  • Company Age 1 Year 10 Days
Company report

Genifloz Pharmacon Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Genifloz Pharmacon Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Genifloz Pharmacon Private Limited?
Current Directors
Name Designation Appointment Date Status
Prasenjit Goswami Director 14 Feb 2025 Current
Manjulika Sardar Director 14 Feb 2025 Current
Siddhartha Sankar Roy Additional Director 09 Jun 2025 Current
Souvick Dey Additional Director 09 Jun 2025 Current
Quazi Mowaz Ahmed Additional Director 09 Jun 2025 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Genifloz Pharmacon.
Genifloz Pharmacon revenue growth over time
Genifloz Pharmacon profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Genifloz Pharmacon?

Unlock access to Genifloz Pharmacon's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Genifloz Pharmacon?

Unlock and access historical data on people associated with Genifloz Pharmacon, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Genifloz Pharmacon, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Genifloz Pharmacon's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Genifloz Pharmacon
Recent Activity within the Organization
  • Director Appointment

    The activity Siddhartha Sankar Roy was appointed as a Additional Director was appointed as a Additional Director on 09 Jun 2025 & has been associated with this company since 8 months 17 days . was completed.

  • Director Appointment

    Souvick Dey was appointed as a Additional Director was appointed as a Additional Director on 09 Jun 2025 & has been associated with this company since 8 months 17 days . was recorded as a recent event.

  • Director Appointment

    Progress on Quazi Mowaz Ahmed was appointed as a Additional Director was appointed as a Additional Director on 09 Jun 2025 & has been associated with this company since 8 months 17 days . was documented.

  • Director Appointment

    The activity Prasenjit Goswami was appointed as a Director was appointed as a Director on 14 Feb 2025 & has been associated with this company since 1 year 10 days . was completed.

  • Director Appointment

    Manjulika Sardar was appointed as a Director was appointed as a Director on 14 Feb 2025 & has been associated with this company since 1 year 10 days . was recorded as a recent event.

  • Company Incorporation

    Genifloz Pharmacon Private Limited was registered on 14 Feb 2025 with Roc Kolkata & aged 1 year 10 days as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Genifloz Pharmacon Private Limited?

The CIN of Genifloz Pharmacon Private Limited is U21001WB2025PTC276443.

Where is Genifloz Pharmacon Private Limited headquartered?

Genifloz Pharmacon Private Limited is headquartered at P-183, C.I.T. Road,, Phool Bagan, Beleghata, Beleghata, West Bengal, 700010.

When was Genifloz Pharmacon Private Limited incorporated?

Genifloz Pharmacon Private Limited was incorporated on 14 February 2025.

Who are the current directors of Genifloz Pharmacon Private Limited?

The current directors of Genifloz Pharmacon Private Limited are

What is the primary industry of Genifloz Pharmacon Private Limited?

The primary industry of Genifloz Pharmacon Private Limited is Paper.

Is Genifloz Pharmacon Private Limited a listed company?

Genifloz Pharmacon Private Limited is unlisted.

What is the capital structure of Genifloz Pharmacon Private Limited?

The authorized capital of Genifloz Pharmacon Private Limited is ₹1.50 M, and the paid-up capital is ₹0.20 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available